«They also imply that MenaINV expression and TMEM score measure related aspects of a commonly used mechanism that
human breast cancers use to metastasize.»
Not exact matches
Using the modified system,
human melanoma and
breast cancers as well as mouse melanoma cells were diagnosed with greater ease and efficiency.
Using this biosensor in highly invasive
breast cancer cells taken from rodents and
humans, the Einstein team discovered that when an individual invadopodium forms and is actively degrading the ECM, its Rac1 levels are low; on the other hand, elevated Rac1 levels coincide with the invadopodium's disappearance.
To see whether
cancer stem cell renewal involves a chain of events similar to that
used by embryonic stem cells, and whether the process was affected by oxygen levels, Semenza and graduate student Chuanzhao Zhang focused their studies on two
human breast cancer cell lines that responded to low oxygen by ramping up production of the protein ALKBH5, which removes methyl groups from mRNAs.
Exploiting the same pre-clinical model
used for their studies, the researchers are testing the efficacy of this kind of drug candidates against
cancer stem cells, and the possibility of identifying combination regimens with standard chemotherapies with minimized toxic effects, with the perspective of their possible application for the treatment of
human breast cancer.
Additional experiments
using a combination of maraviroc and a drug that blocks the VEGF protein suggest that the treatment duo could be an effective way to prevent metastatic disease in
human breast cancer patients, according to the researchers.
Eran Andrechek, a physiology professor in the College of
Human Medicine at Michigan State University, has discovered that many of the various models used in breast cancer research can replicate several characteristics of the human disease, especially at the gene l
Human Medicine at Michigan State University, has discovered that many of the various models
used in
breast cancer research can replicate several characteristics of the
human disease, especially at the gene l
human disease, especially at the gene level.
In the lab, the scientific team
used an approach that combined functional RNAi analysis with gene expression analysis in
breast cancer - derived cell lines and in
human breast cancers replicated in mice.
Using these multidimensional datasets for
human breast cancer, PLK4 was identified as a candidate target among 10,000 other targets for the development of anticancer therapeutics.
Using all the existing data that was available, Andrechek, along with MSU doctoral student Daniel Hollern, analyzed 1,172 mouse mammary tumor samples from 26 different preclinical models and was able to compile one of the largest databases to show which strains of mice were best suited to study a particular type of
human breast cancer.
Human breast tumors transplanted into mice are excellent models of metastatic
cancer and are providing insights into how to attack
breast cancers that no longer respond to the drugs
used to treat them, according to research from Washington University School of Medicine in St. Louis.
«If further studies validate that these processes are critical in
human breast cancers,» Koshy notes, «the possibility exists that agents that favorably modify the biophysical properties of the extracellular matrix, or that target the receptors and signaling molecules associated with how cells sense this matrix, could be
used as a new avenue for the prevention or treatment of
breast cancers.»
A new study from the University of Illinois reports long - lasting cognitive impairments in mice when they are administered a chemotherapy regimen
used to treat
breast cancer in
humans.
This study provides one of the first animal models to demonstrate the long - term cognitive deficits resulting from a chemotherapeutic treatment
used in treating
humans for
breast cancer.
The analysis of doxorubicin resistance in
human breast cancer cells
using antibody microarrays.
Immunohistochemistry of paraffin - embedded
human breast cancer slide
using 60004 -1-Ig (GAPDH Antibody) at dilution of 1:50
Dr. Jos Jonkers» research group studies the genetic basis of
human breast cancer,
using advanced mouse models for p53 - induced
breast cancer, BRCA1 - and BRCA2 - associated hereditary
breast cancer, and E-cadherin mutated invasive lobular carcinoma.
«In particular, his approach can be thought of as a very advanced biological therapy for the treatment of
breast cancer; one that
uses viruses, which are better recognized to cause disease, to treat
human breast cancers.»
The study
used three cell types:
human motor neurons derived from induced pluripotent stem cells, rat cortical cultures, and
human breast cancer cells.
Using cutting - edge techniques enabled by next - generation sequencing, the authors generated complete methylome maps at single nucleotide resolution in a low - passage
breast cancer cell line and normal
breast tissue (primary
human mammary epithelial cells).
Immunohistochemistry of paraffin - embedded
human breast cancer tissue slide
using 66240 -1-Ig (beta Tubulin antibody at dilution of 1:400 (under 10x lens)
A major focus of their current
cancer research is
using animal, cell - based, molecular, and biophysical approaches to investigate the role of HIF - 1 in vascular and lymphatic metastasis of
human breast cancer.
Conditions for hypoxia / reoxygenation cycles were optimized
using two
human metastatic
breast cancer cell lines (MDA - MB 231 and BCM2).
Immunohistochemistry of paraffin - embedded
human breast cancer tissue slide
using 10379 -1-AP (SNRPD3 Antibody) at dilution of 1:50 (under 10x lens)
Using RNA interference (RNAi), first author Richard Possemato targeted these genes in
human breast cancer cells implanted in mice.
«It is believed that environmental and lifestyle factors, such as diet, play a critical role in increasing
human breast cancer risk, and so we
use animal models to reveal the biological mechanisms responsible for the increase in risk in women and their female progeny,» says Hilakivi - Clarke.
Then,
using semi-quantitative real - time PCR, we found that the expression of miR - 142 was able to upregulate the expression of miR - 150 in
human breast cancer MDA - MB - 231 cells (Figure 5C).
(21 - 22)(39) Three previous large scale
human studies revealed increased
breast cancer with progestin
use.
Dr. Lakshmanaswamy
used a mouse model which mimiced
breast cancer in
humans.
Excessive proliferation of
human breast cancer cells is never good, so countries in Europe started banning and restricting the
use of these chemicals.
Guidelines for the appropriate
use of herbs in
human preliminary research see promise in the
use of dandelion as an anti-
cancer agent for both
breast and prostate
cancer.
According to Lise Alschuler, author of the Definitive Guide To
Cancer: An Integrative Approach to Prevention, Treatment, and Healing, studies on flax lignans demonstrate safety and efficacy in their use against breast cancer, «inhibiting the growth of human estrogen - dependent breast cancer cells in mice and strengthening the tumor - inhibitory effect of tamoxifen&r
Cancer: An Integrative Approach to Prevention, Treatment, and Healing, studies on flax lignans demonstrate safety and efficacy in their
use against
breast cancer, «inhibiting the growth of human estrogen - dependent breast cancer cells in mice and strengthening the tumor - inhibitory effect of tamoxifen&r
cancer, «inhibiting the growth of
human estrogen - dependent
breast cancer cells in mice and strengthening the tumor - inhibitory effect of tamoxifen&r
cancer cells in mice and strengthening the tumor - inhibitory effect of tamoxifen».
Tamoxifen, a product commonly
used for
human breast cancer, is ineffective and has the potential for serious side effects in dogs.
It has also been found that a drug called megesterol (Megace), which is
used in
human breast cancer as well as a birth control product; medroxyprogesterone acetate (Depo - Provera) will also cause this disease to go into remission.
In the 1990s, several reports linked DDT to
human cancers [3] and [4] and the insecticide was found in
breast milk; [5] however, WHO continued to promote DDT
use.
The court's ruling overturned a lower court decision that voided a patent held by Myriad Genetics on BRCA1 and BRCA2, two
human genes
used in determining the risk that women face with
breast and ovarian
cancer.